Ascendis: Why I'm Sceptical On Takeover Rumours, Long-Term Targets
Source: SeekingAlpha
2026-01-25 22:39:50 ET
Investment Overview
The stock of Ascendis Pharma ( ASND ) has risen in value by >1,000% over the past decade, climbing from a price of ~$20, to >$235 per share at the time of writing. Stock is also up >85% on a 1-year basis....
Read the full article on Seeking Alpha
For further details see:
Ascendis: Why I'm Sceptical On Takeover Rumours, Long-Term Targets
Ascendis Pharma A/S
NASDAQ: ASND
ASND Trading
1.29% G/L:
$241.61 Last:
166,300 Volume:
$239.73 Open:
ASND Latest News
March 02, 2026 08:43:00 am
Ascendis Pharma to Participate in the TD Cowen 46th Annual Health Care Conference
February 27, 2026 05:57:16 pm
FDA Approves Once-Weekly YUVIWEL® (navepegritide) for Children with Achondroplasia Aged 2 Years and Older
ASND Stock Data
$13,394,473,228
60,082,592
N/A
105
N/A
Biotechnology & Life Sciences
Healthcare
DK
Hellerup
